Company / PP&E per Share
Travere Therapeutics, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.05
FY2025
5-year range
$0.05 / $0.21
FY2021-FY2025
Trend
-35.0%
vs FY2024
Sector context
#120 of 191
Health Care
What the data says
At $0.05, Travere Therapeutics, Inc.'s pp&e per share ranks #120 of 191 in the Health Care sector. PP&E per Share has declined for 5 consecutive years, from $0.22 in FY2020 to $0.05 in FY2025.
Based on SEC 10-K filings.
0.05 in FY2025 with a 5-year CAGR of -26.8%.
Declined from $0.12 to $0.05 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -31.8%
- 5-Year CAGR
- -26.8%
- 10-Year CAGR
- -
Sector benchmark
#120 of 191 in Health CareTop 63% of 191This company $0.05 Sector average $22.34
▼
-99.8% below sector average
Key checks
Key Insights
- Travere Therapeutics, Inc.'s pp&e per share has declined for 5 consecutive years.
- In FY2025, pp&e per share decreased 35.0% year-over-year.
- Ranks #120 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | -35.0% |
| FY2024 | $0.07 | -39.1% |
| FY2023 | $0.12 | -19.7% |
| FY2022 | $0.14 | -31.9% |
| FY2021 | $0.21 | -2.7% |
| FY2020 | $0.22 | +212.9% |
| FY2019 | $0.07 | -12.6% |
| FY2018 | $0.08 | -6.2% |
| FY2017 | $0.09 | +20.1% |
| FY2016 | $0.07 | +331.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026